期刊文献+

原发性肝癌患者介入治疗前后血清Dickkopf-1表达变化 被引量:1

Changes of Serum Dickkopf-1 Level before and after Intervention Therapy for Primary Liver Cancer
下载PDF
导出
摘要 目的观察原发性肝癌患者介入治疗前后血清Dickkopf-l(DKKl)表达水平的变化。方法采用ELISA法,检测40例健康体检者(对照组)以及87例原发性肝癌患者介入治疗前后血清DKKl水平并进行比较。结果对照组与Ⅱ、Ⅲ期原发性肝癌患者血清DKK1水平比较差异有统计学意义(P<0.05);原发性肝癌患者介入治疗后血清DKK1水平与治疗前比较,差异有统计学意义(P<0.05)。结论 DKK1可以作为评价原发性肝癌疗效和预后的指标。 Objective To observe the changes of serum Dickkopf-1 (DKK1) level before and after intervention therapy for primary liver cancer .Methods Serum DKK1 levels in 40 healthy patients ( control group ) and 87 primary liver cancer pa-tients before and after intervention therapy were compared .Results There was significant difference in the serum DKK 1 level a-mong control group,stage Ⅱand Ⅲprimary liver cancer patients (P<0.05).The serum DKK1 level was significantly different before and after the intervention therapy (P<0.05).Conclusion DKK1 can be used as a predictor for the prognosis of primary liver cancer .
机构地区 解放军第
出处 《实用癌症杂志》 2014年第11期1390-1392,共3页 The Practical Journal of Cancer
关键词 Dickkopf-l 原发性肝癌 介入治疗 疗效 Dickkopf-l Primary liver cancer Intervention therapy Clinical efficacy
  • 相关文献

参考文献12

二级参考文献125

共引文献1138

同被引文献16

  • 1Vonderheide RH,Flaherty KT,Khalil M,et al.Clinical activity and immune modulation in cancer patients treated with CP-870,893,a novel CD40 agonist monoclonal antibody[J].J Clin Oncol,2007,25:876-883.
  • 2Eisenhauer EA,Therasse P,Boqaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45:228-47.
  • 3Simonds NI,Khoury MJ,Schully SD,et al.Comparative effectiveness research in cancer genomics and precision medicine:current landscape and future prospects[J].J Natl Cancer Inst,2013,105:929-936.
  • 4Sudul T,Domagala-Kulawik J.Clinical manifestation and radiological features of small cell lung cancer(SCLC)[J].Wiad Lek,2012,65:97-101.
  • 5彭拥军,王超.原发性肝癌肝动脉栓塞介入治疗前后D二聚体变化的临床意义[J].现代消化及介入诊疗,2010,15:311-312.
  • 6Wang NY,Wang C,Li W,et al.Prognostic value of serum AFP,AFP-L3,and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation[J].Aaian Pac J Cancer Prev,2014,15:1539-1544.
  • 7Msch M,Czabanka M,Dengler J,et al.D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma[J].Anticancer Res,2013,33:2093-2098.
  • 8符晓阳,袁记,李汉智.微小剂量肝素在肝癌介入术后DIC预防性治疗中的应用[J].中国误诊学杂志,2010(6):1305-1306. 被引量:2
  • 9熊正平,黄芳,梁赵玉,黄斌,黄满平,李国文,古善智.奈达铂联合氟尿嘧啶栓塞治疗中晚期肝癌的临床观察[J].临床肿瘤学杂志,2011,16(11):1023-1025. 被引量:4
  • 10王晓蕊,黄彩云,韩素桂,张景华,李世龙,周秀艳.原发性肝癌患者血清中AFP-L3、GP73检测的评价[J].标记免疫分析与临床,2012,19(6):330-333. 被引量:11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部